Genkwanin

Genkwanin

SCHEMBL5469869

COc1cc(O)c2c(=O)cc(-c3ccc(O)cc3)oc2c1.COc1cc(O)c2c(c1)OC(c1ccc(O)cc1)CC2=O

nearest known ligand 0.74

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 5/20 0.74
MAPT P10636 3/20 0.74
TDP1 Q9NUW8 3/20 0.74
ALDH1A1 P00352 2/20 0.74
ADORA3 P0DMS8 1/20 0.74
ATM Q13315 1/20 0.74
TAS2R31 P59538 1/20 0.74
MMP9 P14780 2/20 0.68
FLT3 P36888 2/20 0.66
IP6K2 Q9UHH9 2/20 0.66
MKNK2 Q9HBH9 1/20 0.66
ABCG2 Q9UNQ0 2/20 0.63
MMP2 P08253 1/20 0.63
MMP3 P08254 1/20 0.63
CYP1A1 P04798 3/20 0.60
CYP1A2 P05177 3/20 0.60
CYP1B1 Q16678 3/20 0.60
MAOB P27338 2/20 0.60
BACE1 P56817 2/20 0.59
CYP3A4 P08684 4/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acacetin SCHEMBL891690 0.93 MMP9 (0.71) CYP19A1MAPTTDP1ALDH1A1ADORA3
Naringenin SCHEMBL28072458 0.88 BACE1 (0.70) CYP19A1MAPTTDP1ALDH1A1ADORA3
Naringenin SCHEMBL6073059 0.88 BACE1 (0.70) CYP19A1MAPTTDP1ALDH1A1ADORA3
Naringenin SCHEMBL28072460 0.88 BACE1 (0.70) CYP19A1MAPTTDP1ALDH1A1ADORA3
Homoeriodictyol SCHEMBL17651827 0.86 MMP9 (0.72) CYP19A1MAPTTDP1ALDH1A1ATM
Sakuranetin SCHEMBL555541 0.86 CYP19A1 (1.00) CYP19A1MAPTTDP1ALDH1A1ADORA3
Sakuranetin SCHEMBL555542 0.86 CYP19A1 (1.00) CYP19A1MAPTTDP1ALDH1A1ADORA3
Sakuranetin SCHEMBL29928748 0.86 CYP19A1 (1.00) CYP19A1MAPTTDP1ALDH1A1ADORA3
Sakuranetin SCHEMBL14410473 0.86 CYP19A1 (1.00) CYP19A1MAPTTDP1ALDH1A1ADORA3
SCHEMBL16710297 0.81 CYP19A1 (0.90) CYP19A1MAPTTDP1ALDH1A1ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070299018-A1 Derivatives of Genkwanin and Sakuranetin, Cosmetic and Therapeutic Use Thereof and Preparation Method of Same PROST MICHEL 2007-12-27 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070299018-A1 Derivatives of Genkwanin and Sakuranetin, Cosmetic and Therapeutic Use Thereof and Preparation Method of Same GLA, OGA, UGCG CYP19A1 180/4885MAPT 4503/4885TDP1 4501/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.